According to Value Market Research projection, the Global Microbiome Therapeutics Market was valued USD 24.4 Million (by revenue) in 2017 and is anticipated to reach USD 327.9 Million by 2024 with a CAGR of 45.7%.The rising population affected by inflammatory bowel diseases is the prime factor driving the microbiome therapeutics market. Rising need for the development of novel drugs along with the increasing investment by government in microbiome research is likely to drive the market growth. Also, improved microbiome sequencing capabilities is another major factor expected to support the growth of the market. Moreover, the advancement in microbiome technologies will also help to shape the market growth in a positive direction.
Microbiomes refers to the microorganisms such as bacteria, archaea, and fungi that reside on skin layers, and in saliva, conjunctiva, oral mucosa and the gastrointestinal tract (GIT) of the human body. Despite being parasites, these microorganisms are beneficial for the human host in maintaining good health. Currently, researchers are focusing on improving their efficiency in medical treatment for serious disease by developing a new therapy. These research studies are currently in clinical development and are expected to raise the demand for microbiomes. Microbiome therapeutics find extensive applications in various fields, such as Crohn’s disease, C. difficile infections, Inflammatory Bowel Disease (IBD), and diabetes.
The report "Global Microbiome Therapeutics Market segmented By Type (FMT and Microbiome Drugs), Application (C. Difficile, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation, and Forecast, 2017-2024” - is an in-depth coverage of the global microbiome therapeutics market including key current trends, growth, challenges, and opportunities would help professionals to understand market behavior with clarity.
The global microbiome therapeutics market is segmented on the basis of type, application, and region. By type, the market is divided into FMT and microbiome drugs. Fecal Microbiota Transplant (FMT) segment is rapidly gaining hype in the market owing to its cost-effective, low risk and is a highly effective treatment. Microbiome has various application such as C. Difficile, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes, Others. Out of which, C. Difficile has shown the promising result in treatment of life-threatening infections. In terms of geography, the market has been studied across the top five major regions i.e. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is accounted for the highest market share in the global microbiome therapeutics owing to the growing number of aging population along with the rising investment in R & D for the development of advanced novel therapeutics.
The Report Segments Global Microbiome Therapeutics Market -
Major Players Profiled In The Report:
Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome, and Seres Therapeutics Inc. are the major players in the global microbiome therapeutics market.
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]